Respiri Ltd
ASX:RSH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pantera Silver Corp
XTSX:PNTR
|
CA |
|
3
|
3U Holding AG
XETRA:UUU
|
DE |
|
J
|
Jiangsu Changshu Automotive Trim Group Co Ltd
SSE:603035
|
CN |
|
Lennox International Inc
NYSE:LII
|
US |
|
Hunan Sokan New Materials Co Ltd
SSE:688157
|
CN |
|
K
|
King Stone Energy Group Ltd
HKEX:663
|
HK |
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| AU |
R
|
Respiri Ltd
ASX:RSH
|
55.1m AUD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
168.1B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
166.6B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
131.3B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.6B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
95.3B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.9B EUR |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47B USD |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
47B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.1B USD |
Loading...
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
34B USD |
Loading...
|
Market Distribution
| Min | -6 907 100% |
| 30th Percentile | 21.6% |
| Median | 38.3% |
| 70th Percentile | 58.2% |
| Max | 2 095.9% |
Other Profitability Ratios
Respiri Ltd
Glance View
Respiri Ltd. engages in research, development, and commercialization of medical devices and the production of mobile health applications for management of asthma and related chronic respiratory diseases. The company is headquartered in Melbourne, Victoria. The company went IPO on 2000-07-14. The firm's segments include Australia and Israel. The Australia segment is engaged in research, development and commercialization of medical devices, and the production of mobile health applications in Australia. The Israel segment is engaged in research, development and commercialization of medical devices, and the production of mobile health applications in Israel. The firm has developed a wheezo, which is an eHealth Saas platform that uses a device and app to measure, record and assist asthma monitoring. Its device and app make up a cloud-based mobile health platform that records wheeze and other clinically relevant symptoms and signs of asthma.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Respiri Ltd is 83.4%, which is below its 3-year median of 92.5%.
Over the last 3 years, Respiri Ltd’s Gross Margin has increased from 42.6% to 83.4%. During this period, it reached a low of 42.6% on Dec 31, 2021 and a high of 99.6% on Jun 30, 2024.
